Key Rating Drivers & Detailed Description
Strengths:
* Support from parent and majority owner, ICICI Bank Ltd is expected to continue over due course
ICICI Lombard's strategic importance to ICICI Bank is underpinned by the former's leadership position among private sector general insurance companies. Furthermore, ICICI Lombard being the general insurance arm of ICICI Bank makes it a key element of the latter's bouquet of financial service offerings. ICICI Lombard benefits from common branding with its parent, which is one of the large private sector banks in India with a strong retail and corporate presence, established franchise, and large customer base. The company also derives managerial and funding support from ICICI Bank, the former is reflected in the representation of ICICI Bank's directors on ICICI Lombard's board, and the bank's high involvement in the latter's functioning. ICICI Bank has demonstrated track record of extending capital support to ICICI Lombard whenever needed and such support is expected to continue. Even after the listing of ICICI Lombard in September 2017, ICICI Bank has maintained majority stake in ICICI Lombard and currently holds 51.87% in the subsidiary.
As a consideration for its scheme of arrangement with Bharti AXA which was underway since August 2020, shareholders of Bharti AXA - Bharti General Ventures Pvt Ltd (Bharti) and Societe Beaujon (AXA) were allotted fresh 35.7 million shares of the resulting entity - ICICI Lombard in a ratio of 51:49 leading to a dilution in the stake of ICICI Bank in the subsidiary. Resultantly, the stake held by ICICI Bank in ICICI Lombard has reduced from 51.9% to 48.1% as of September 8, 2021. However, even post divestment of stake, CRISIL Ratings understands that there will be no change in stance of support (both financial and Board oversight) provided by ICICI Bank to ICICI Lombard. ICICI Bank remains to be the single largest shareholder in ICICI Lombard and retains Board control. Further, CRISIL Ratings believes that ICICI Bank will continue to consolidate ICICI Lombard fully within its financial reporting due to management control. Any further, significant reduction in shareholding of ICICI Bank in, or a material change in strategic importance of, ICICI Lombard, will be a key rating sensitivity factor.
* Sustenance in leadership position among private general insurers
With a market share of 7.0% based on gross direct premiums written during fiscal 2021, ICICI Lombard has retained its leadership among private general insurers in India and, remains the fourth largest non-life insurer in the country. Including the effect of the scheme with Bharti Axa, the resultant entity – ICICI Lombard – had a pro-forma market share of over 8.6% based on gross premiums for fiscal 2021 and ranked as the second largest general insurer in the industry. During fiscal 2021, ICICI Lombard underwrote a total direct premium of Rs 14,003 crore at a standalone level – which marks an annual growth of 5.2% over last year which is at par with industrial growth over the same period. Gross premiums for the merged entity stood at Rs 17,504 crore on a proforma basis and almost one-fifth of this was contributed by Bharti Axa. In Q1 2022, the merged entity wrote gross premiums of Rs 4,267 crore on a proforma basis.
In terms of premium mix across segments on a proforma basis, motor insurance remains the largest contributor accounting for 33% of the gross premiums underwritten by the merged entity during Q1 2022. Fire, with a share of 25% in gross premiums, has overtaken health insurance to become the second largest segment. This robust growth in the fire segment was witnessed across players in the industry and was driven by a favourable revision in rates w.e.f January 2020. Health, driven by increased awareness post Covid-19 outbreak, sustained its growth momentum and accounted for 23% of the gross premiums of the merged entity for Q1 2022. By virtue of this scheme coming into effect, the share of crop insurance in the total premium portfolio of merged entity, is also expected to increase to ~5-6% from nil.
After the merger, apart from the immediate benefit of increased market share – ICICI Lombard would also have access to a larger, wider channel base and its benefits to scale will materialize in the long run.
* Healthy capitalization and expected sustenance of high cushion in solvency ratio over regulatory stipulation
Capitalisation, at a standalone level, remains healthy reflected in a large networth of Rs 7,592 crore, a comfortable solvency ratio of 2.76 times, and unrealized gain on equity portfolio at Rs. 772 crore as as on June 30, 2021. On the same date, the merged entity had a pro-forma networth of Rs 9,868 crore, a comfortable solvency ratio of 2.57 times and, a balance of Rs 776 crore in the fair value change account.
Apart from its healthy internal accruals generated over the years, ICICI Lombard’s capital position is also supported by timely capital infusion from ICICI Bank, in times of need, as demonstrated in the past.
The company’s solvency position has remained strong over the years – reflected in the high margin it maintains over regulatory stipulation of 1.5 times. Over the medium term, ICICI Lombard's solvency ratio is expected to remain comfortably above than the regulatory requirement and the parent - ICICI Bank is also supportive of this stance. In a scenario where loss ratio rises to beyond expectation due to Covid claims, there could be momentary variation in solvency ratio and the same remains a key monitorable.
The cushion in the solvency ratio over the regulator-specified minimum will remain a rating sensitivity factor, given the likelihood of default in debt servicing on the subordinated debt instrument if the ratio falls below the stipulated minimum.
* Sound quality of the investment portfolio
100% of the company's debt investments were in sovereign securities or corporate debt instruments rated 'AA' or better as on June 30, 2021. In addition, the company’s liquidity is comfortable, backed by a large proportion of liquid investments. Government securities (G-secs), both state and central, accounted for 41% of its debt portfolio at amortized costs whereas equity investments at market value - accounted for close to 14% of its investment book. The share of liquid mutual funds stood at 2.4% as on June 30, 2021. The quality of ICICI Lombard's investment portfolio is expected to remain strong supported by its prudent investment policy in addition to stringent regulatory guidelines.
Weakness:
* Modest, though gradually improving, underwriting performance
At a standalone level, ICICI Lombard reported an underwriting deficit of Rs 192 crore for fiscal 2021 which translated to a combined ratio of 99.8%. During this period, claims ratio declined to 68.6% from 72.9% for the previous fiscal – on account of lower non-Covid related claims incurred. For the merged entity, underwriting deficit for the year was Rs 406 crore corresponding to a combined ratio of 101.2% - which is in line with CRISIL Ratings’ earlier expectation for the resultant entity.
During fiscal 2021, the total Covid-19 claims (including IBNR) incurred by the company on a standalone basis were Rs 339 crore. These Covid-19 claims incurred by the company were against its standard Corona products as well as its traditional medi-claim policyholders. However, claims for non-Covid illnesses and casualties and other accidents, were lower because of restricted public activity and vehicular traffic.
Subsequent to the second wave, which witnessed higher severity and frequency of casualties, and with penetration of health insurance having increased in the past year, total Covid-19 claims reported and honoured in the first quarter of fiscal 2022 were almost equivalent to the Covid-19 claims incurred in fiscal 2021. As against Rs 7,832 crore of Covid-19 claims settled by the non-life insurance industry in fiscal 2021, claims incurred in the first quarter of fiscal 2022 amounted to Rs 7,768 crore. ICICI Lombard, on a standalone basis, has incurred Rs 602 crore worth of Covid-19 claims in the first quarter of fiscal 2022, which accounted for 24.4% of the total claims incurred by the company during the quarter. Of this, Rs 384 crore worth of claims have been indemnified whereas, balance are carried as IBNR. While the instances of Covid-19 claims have been declining since June 2021, the adequacy of reserving done by the company against potential Covid-19 claims which are incurred but not reported or are partially reported, will remain a monitorable. With increased exposure to crop segment post implementation of the arrangement scheme, the ability of the company to maintain underwriting performance within this segment also remains critical.